Morphological findings in explanted Toronto stentless porcine valves

Butany, 2001, The failure modes of biological prosthetic heart valves, J Long-Term Eff Med Implants, 11, 115, 10.1615/JLongTermEffMedImplants.v11.i34.30 Park, 2000, Current status of stentless aortic xenografts, Curr Opin Cardiol, 15, 74, 10.1097/00001573-200003000-00002 David, 1998, Aortic valve replacement with stentless porcine aortic valves: a ten-year experience, J Heart Valve Dis, 7, 250 Goldman, 1999, Will stentless valves be durable? The Toronto valve (TSPV) at 5 to 6 years, Semin Thorac Cardiovasc Surg, 11, 42 Bach, 2004, Durability and prevalence of aortic regurgitation nine years after aortic valve replacement with the Toronto SPV stentless bioprosthesis, J Heart Valve Dis, 13, 64 Ishihara, 1981, Structure and classification of cuspal tears and perforations in porcine bioprosthetic cardiac valves implanted in patients, Am J Cardiol, 48, 665, 10.1016/0002-9149(81)90145-4 Butany, 1999, Morphologic findings in explanted Hancock II porcine bioprostheses, J Heart Valve Dis, 8, 4 David, 2004, Ten-year results of aortic valve replacement with Toronto SPV bioprosthesis Banbury, 1998, Long-term results of the Carpentier–Edwards pericardial aortic valve: a 12-year follow-up, Ann Thorac Surg, 66, S73, 10.1016/S0003-4975(98)00986-2 David, 2001, Late results of heart valve replacement with the Hancock II bioprosthesis, J Thorac Cardiovasc Surg, 121, 268, 10.1067/mtc.2001.112208 Butany, 1992, Morphologic findings and causes of failure in 24 explanted Ionescu–Shiley low-profile pericardial heart valves, Hum Pathol, 23, 1224, 10.1016/0046-8177(92)90289-F Butany, 1999, The Toronto SPV bioprosthesis: review of morphological findings in eight valves, Semin Thorac Cardiovasc Surg, 11, 157 David, 2001, Dilation of the sinotubular junction causes aortic insufficiency after aortic valve replacement with the Toronto SPV bioprosthesis, J Thorac Cardiovasc Surg, 122, 929, 10.1067/mtc.2001.118278 Shargall, 2001, Analysis of explants and causes of mortality during long-term follow-up of the Toronto stentless porcine valve, Semin Thorac Cardiovasc Surg, 13, 106 Butany, 2003, Stentless porcine valves: new mode of failure, Can J Cardiol, 19, 185 Keane, 2000, Bicuspid aortic valves are associated with aortic dilatation out of proportion to coexistent valvular lesions, Circulation, 102, III35, 10.1161/01.CIR.102.suppl_3.III-35 Bortolotti, 1994, Hancock II porcine bioprosthesis: excellent durability at intermediate-term follow-up, J Am Coll Cardiol, 24, 676, 10.1016/0735-1097(94)90014-0 Bottio, 2003, Hancock II bioprosthesis: a glance at the microscope in mid-long-term explants, J Thorac Cardiovasc Surg, 126, 99, 10.1016/S0022-5223(03)00131-4 Butany, 1994, Pathology of explanted stentless porcine valves (human experience), 183 Tansley, 2000, Symptomatic calcific stenosis of a Toronto stentless porcine valve, Eur J Cardiothorac Surg, 17, 763, 10.1016/S1010-7940(00)00437-1 Mirzaie, 1999, Calcification tendency of various biological aortic valves in an experimental animal model, Cardiovasc Surg, 7, 735, 10.1016/S0967-2109(99)00057-5 Golomb, 1987, The role of glutaraldehyde-induced cross-links in calcification of bovine pericardium used in cardiac valve bioprostheses, Am J Pathol, 127, 122 Broom, 1979, Influence of fixation conditions on the performance of glutaraldehyde-treated porcine aortic valves: towards a more scientific basis, Thorax, 34, 166, 10.1136/thx.34.2.166 Dunmore-Buyze, 1995, A comparison of macroscopic lipid content within porcine pulmonary and aortic valves. Implications for bioprosthetic valves, J Thorac Cardiovasc Surg, 110, 1756, 10.1016/S0022-5223(95)70039-0 Schoen, 1999, Founder's Award, 25th Annual Meeting of the Society for Biomaterials, perspectives. Providence, RI, April 28–May 2, 1999. Tissue heart valves: current challenges and future research perspectives, J Biomed Mater Res, 47, 439, 10.1002/(SICI)1097-4636(19991215)47:4<439::AID-JBM1>3.3.CO;2-F Bailey, 2003, Role of elastin in pathologic calcification of xenograft heart valves, J Biomed Mater Res, 66A, 93, 10.1002/jbm.a.10543 Shi, 1999, Role of matrix metalloproteinases and their tissue inhibitors in the regulation of coronary cell migration, Arterioscler Thromb Vasc Biol, 19, 1150, 10.1161/01.ATV.19.5.1150 Rabkin, 2001, Activated interstitial myofibroblasts express catabolic enzymes and mediate matrix remodeling in myxomatous heart valves, Circulation, 104, 2525, 10.1161/hc4601.099489 Vyavahare, 2000, Inhibition of matrix metalloproteinase activity attenuates tenascin-C production and calcification of implanted purified elastin in rats, Am J Pathol, 157, 885, 10.1016/S0002-9440(10)64602-0